Students and their supervisors

This page lists the PhD students of the three currently active cycles:

  • XXXV cycle (01.10.2019 - 30.09.2022)
  • XXXVI cycle (01.10.2020 - 30.09.2023)

  Francesco PIERANTONI

XXXVI Cycle (01.10.2020-30.09.2023)

Research area: Urothelial carcinoma

Supervisor: Dott.ssa Vittorina Zagonel

The aim of my research project is to analyze biomarkers which may be able to predict the efficacy of different therapies on patients affected by urothelial carcinoma of the bladder or upper urinary tract.

  Mario Domenico RIZZATO

XXXVI Cycle (01.10.2020 - 30.09.2023)

RESEARCH AREA: Biliary Tract Cancers

SUPERVISOR: Dr. Sara Lonardi

The main aim of my project is to improve the knowledge on the molecular alterations in biliary tract cancers and the research of new prognostic and predictive factors


XXXVI Cycle (01.10.2020-30.09.2023)

Research area: Hepatocellular Carcinoma

Supervisor: Prof. Patrizia Burra

The aim of the study is to evaluate the prevalence of non-neoplastic portal vein thrombosis, its natural history and prognostic role in a cohort of cirrhotic patients with hepatocellular carcinoma.

  Edoardo RUGGERI

XXXV Cycle (01.10.2019-30.09.2022)

Research area: Hematological malignancies

Supervisor: Prof. Monica Facco

My research project concerns the identification of new molecular targets in classical Hodgkin’s Lymphoma. It is focused on the PD-1 / PD-L1 axis and on T lymphocyte immunosuppression in the tumor microenvironment.

  Federica MIGLIETTA

XXXVI Cycle (01.10.2020-30.09.2023)

Research area: Biological characterization of breast cancer

Supervisor: Prof.ssa Valentina Guarneri

My research acivity is focused on the biological characterization of breast cancer. In particular, the aim of my PhD is the evaluation of the prognostic and/or predictive role of clinical, pathological and molecular biomarkers.

  Alessandro PENNA

XXXVI Cycle (01.10.2020-30.09.2023)

Research area: Adoptive Cell Therapy

Supervisor: Prof. Antonio Rosato 

Tumor immunology is my laboratory’s main field. In particular, my PhD research project is focused on the use of novel adoptive cell therapies, specifically CAR-transduced effector lymphocytes, and new therapeutic strategies against solid tumors.


XXXVI Cycle (01.10.2020-30.09.2023)

Research area: T-cell transformation

Supervisor: Prof. Vincenzo Ciminale

The aim of my PhD project is to identify the critical hubs controlling redox homeostasis and cell death pathways in T-cell acute lymphoblastic leukemia (T-ALL). This knowledge will be essential for the development of novel pharmacological strategies to treat drug-resistant T-ALL

  Alessandro DAL MASO

XXXVI Cycle (01.10.2020-30.09.2023)

Research area: Clinical and Translational Oncology

Supervisor: Prof. Valentina Guarneri

The aim of my research project is the study of clinical, biohumoral, pathological and molecular biomarkers of immunotherapy response and toxicity.    


XXXVI Cycle (01.10.2020-30.09.2023)

Research area: Hematological malignancies

Supervisor: Prof. Francesco Piazza

The aim of my project is to identify the connections between neoplastic cell metabolism, epigenetic modifications and activation of enzymes, potentially implied in the biogenesis of aggressive lymphoma.


XXXVI Cycle (01.10.2020-30.09.2023)

Research area: Tumor immunology

Supervisor: Prof. Susanna Mandruzzato

The aim of my PhD project is to study the immune suppressive activity exerted by myeloid cells and discover new approaches to revert this suppression in cancer patients. 

  Annavera VENTURA

XXXV Cycle (01.10.2019-30.09.2022)

Research area: Adoptive Cell Therapy

Supervisor: Prof. Antonio Rosato

The aim of my PhD research project is the characterization of the interactions between adoptively transferred murine Cytokine-Induced-Killer (CIK) cells, , cancer cells and the other immune cell populations within the Tumor Micro-Environment.


XXXV Cycle (01.10.2019-30.09.2022)

Research area: Promising use of liquidbiopsy in pancreatic cancer patients

Supervisor: Prof. Sara Lonardi

The aim of my project is to explore the feasibility and potential clinical utility of the circulating tumoral DNA to inform therapy decision making focusing on the prognostic and predictive role of circulating mutant KRAS genes in the blood and in the urine of patients with pancreatic ductal adenocarcinoma.

  Luisa PICCIN


XXXV Cycle

Research area: Cancer Immunotherapy Prognostic and Predictive Factors

Supervisor: Prof. PierFranco Conte

Tutor: Prof. Vanna Chiarion Sileni

My clinical and translational research activity is above all focused on the identification of factors involved in response, longer survival, resistance and toxicity to immunotherapetic strategies in skin cancers (above all Melanoma and Merkel Cell Carcinoma), in order to optimize clinical decisions in this field.


XXXV Cycle (01.10.2019-30.09.2022)

Research area: Gastrointestinal cancers

Supervisor: Prof. Matteo Fassan

The main aim of my project is to explore the gastric and esophageal microbiota in pre-cancerous and cancerous lesions to identify specific bacteria that could plays a role in carcinogenesis

  Lorenzo NICOLE'

XXXV Cycle (01.10.2019-30.09.2022)

Research area: Artificial Intelligence in Pathology research

Supervisor: Prof. Angelo Paolo Dei Tos

The aim of my project is to improve the ability to recognize rare cancers histology developing an AI algorithm able to predict specific fusion-gene alterations in small round cell sarcomas analyzing  hematoxylin&eosin-stained slides


XXXV Cycle (01.10.2019-30.09.2022)

Research area: Genetic predisposition to melanoma

Supervisor: Dr. Chiara Menin

The main aim of the project is to study the genetic factors of familial melanoma, also in the wider context of melanoma syndromes and multiple primary melanomas.

  Nicole CONTRAN

XXXV Cycle (01.10.2019-30.09.2022)

Research area: Colorectal cancer and pancreatic cancer

Supervisor: Prof. Daniela Basso

The overall aim of my project is to discover new biomarkers for the non-invasive early diagnosis of colorectal cancer and pancreatic cancer and to verify their potential role in cancerogenesis.

  Brigida BARBERIO

XXXV Cycle (01.10.2019-30.09.2022)

Research area: Inflammatory Bowel Diseases

Supervisors: Dr Fabiana Zingone, Prof Edoardo Savarino

The aims of my project are:

  • to investigate the role of micro-RNA in the development and natural course of colorectal cancer associated to Inflammatory Bowel Diseases (IBD-CRC);
  • to identify potantial non-invasive and early biomarkers for IBD-CRC screening, progression, and monitoring.


  Antonino Alex CARTALEMI

XXXV Cycle (01.10.2019-30.09.2022)

Research area: Cancer Metabolism

Supervisor: Dr. Giovanni Tonon

The aim of this project is to unravel the metabolic reprogramming caused by the epigenetic deregulation characterizing Multiple Myeloma cells. The metabolic weaknesses will be exploited to test the Myeloma sensitivity to different drugs  targeting specific metabolic pathways

  Aamir AMIN

XXXIV Cycle (01.10.2018-30.09.2021)

Research area: Extra-telomeric functions of Telomerase (TERT)

Supervisor: Prof. Anita de Rossi

The aim of my project is to study the non-canonical functions of TERT in cellular immortalization and identifying its interaction partners with the goal to unravel the cellular pathways being (de)regulated by reactivated telomerase during oncogenic transformatio

  Antonio COLLESEI

XXXVI Cycle (01.10.2020 - 30.09.2023)

Research area: Bioinformatics and Computational Oncology

Supervisors: Dr. Francesca Schiavi, Prof. Fabio Vandin, Dr. Rita Zamarchi

As a Bioengineer, my objective is to tackle increasingly complex datasets by implementing Machine Learning models and statistical tools. My current focus is turned toward understanding tumor heterogeneity and clonality through analysis of germline and somatic variants.